dr. MW Kroon

Marije Kroon is a dermatologist at the Jan van Goyen Medical and Aesthetic Center. She followed her medicine training and specialization as a dermatologist at the UMC Amsterdam. She partly conducted the training at the Flevoziekenhuis in Almere. Koon obtained his PhD on vitiligo and the treatment of various pigment disorders with laser therapy at the Netherlands Institute for Pigment Disorders Foundation. In addition to her work at Jan van Goyen, Kroon works 1 day a week at ZBC Multicare in Hilversum.

'I think the most important thing is that people feel heard and complaints are taken seriously. I go home with a satisfied feeling when patients are satisfied and when, in addition to the medical treatment and/or explanation, there has also been time for a conversation about someone's work, family or hobbies.'

Memberships:

-Dutch Society for Dermatology and Venereology (NVDV)
-Dutch Society for Cosmetic Dermatology (NVCD)
-European Academy of Dermatology and Venerology (EADV)

Publications:

1. Crown MW, Rust RW. A man with a swollen nipple. Ned Magazine Medicine. 2013;157(43):A6067.
2. Crown MW, Vrijman C, Chandeck C, Wind BS, Wolkerstorfer A, Luiten RM, Bos JD, Geskus RB, van Trotsenburg P, van der Veen JP. High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo. Horm Res Pediatr. 2013;79:137-44.
3. Crown MW, Kemp EH, Wind BS, Krebbers G, Bos JD, Gawkrodger DJ, Wolkerstorfer A, van der Veen JP, Luiten RM. Melanocyte antigen-specific antibodies cannot be used as markers for recent disease activity in patients with vitiligo. J Eur Acad Dermatol Venereol. 2013;27:1172-5.
4. Crown MW, Joore IC, Wind BS, Leloup MA, Wolkerstorfer A, Luiten RM, Bos JD, Geskus RB, van der Veen JP. Low yield of routine screening for thyroid dysfunction in asymptomatic patients with vitiligo. Br J Dermatol. 2012;166:532-8.
5. Crown MW, Wind BS, Meesters AA, Wolkerstorfer A, van der Veen JPW, Bos JD, van der Wal AC, Beek JF. Non-ablative 1550nm fractional laser therapy not effective for erythema dyschromicum perstans and postinflammatory hyperpigmentation; a pilot study. J Dermatol Treat.2012;23:339-44.
6. Crown MW, Wind BS, Beek JF, van der Veen JPW, Nieuweboer-Krobotová L, Bos JD, Wolkerstorfer A. Non ablative fractional laser therapy versus triple therapy for the treatment of melasma: a randomized controlled pilot study. J Am Acad Dermatol. 2011;64(3):516-23.
7. Freeman C, Crown MW, Limpens J, Leeflang MM, Luiten RM, van der Veen JP, Wolkerstorfer A, Spuls PI. The prevalence of thyroid disease in patients with vitiligo: a systematic review. Br J Dermatol. 2012;167:1224-35.
8. Wind BS, Masters AA, Crown MW, Beek JF, van der Veen JP, van der Wal AC, Bos JD, Wolkerstorfer A. Formation of fibrosis after nonablative and ablative fractional laser therapy. Dermatol Surg. 2012;38:437-42.
9. Masters AA, Wind BS, Crown MW, Wolkerstorfer A, van der Veen JP, Nieuweboer-Krobotová L, van der Wal AC, Bos JD, Beek JF. Ablative fractional laser therapy as treatment for Becker nevus; a randomized controlled pilot study. J Am Acad Dermatol. 2011;65:1173-9.
10. Wind BS, Masters AA, Crown MW, Beek JF, van der Veen JP, Nieuweboer-Krobotová L, Bos JD, Wolkerstorfer A. Punchgraft testing in vitiligo; effects of UVA, NB-UVB and 632.8nm Helium-Neon laser on the outcome. J Eur Acad Dermatol Venereol. 2011;25:1236-7.
11. wind BS,  Crown MW, Meesters AA, Beek JF, van der Veen JPW, Nieuweboer-Krobotová L, Bos JD, Wolkerstorfer A. Non-ablative fractional laser therapy versus triple topical therapy for the treatment of melasma: a randomized controlled split-face study. Laser Surg Med. 2010;42(7):602-12.
12. wind BS, Crown MW, Beek JF, van der Veen JPW, Nieuweboer-Krobotová L, Bos JD, Wolkerstorfer A. Home versus outpatient narrowband UVB phototherapy for the treatment of non-segmental vitiligo; a retrospective questionnaire study. Br J Dermatol. 2010; 162(5):1142-4.
13. De Snoo FA, Crown MW, Bergman W, ter Huurne JA, Houwing-Duistermaat JJ, van Mourik L, Snels DG, Breuning MH, Willemze R, Frants RR, Gruis NA: From sporadic atypical nevi to familial melanoma: risk analysis for melanoma in sporadic atypical nevus patients. J Am Acad Dermatol. 2007;56:748-52.